The relationship of Parkinson disease with aging - PubMed (original) (raw)
Review
The relationship of Parkinson disease with aging
Gilberto Levy. Arch Neurol. 2007 Sep.
Abstract
Twentieth-century hypotheses attributing a substantive role to aging in Parkinson disease (PD) pathogenesis have been countered by evidence from clinical, pathological, and biochemical investigations. However, age influences the clinical progression of PD. Several studies have demonstrated that advancing age is associated with a faster rate of motor progression, decreased levodopa responsiveness, more severe gait and postural impairment, and more severe cognitive impairment and the development of dementia in patients with PD. A model for the relationship between PD and aging is proposed that incorporates the following 3 elements: (1) There occurs a superposition of a topographic gradient of neuronal loss in brainstem and basal forebrain structures related to the disease process and an aging-related temporal gradient. (2) While PD is a chronic progressive disorder, the most important determinant of clinical progression is advancing age rather than disease duration. (3) The effects of the disease process and aging on nondopaminergic structures involve a biologic interaction. The model implies that understanding the degenerative process in nondopaminergic structures in PD as it relates to molecular mechanisms accompanying the aging of the nervous system may create opportunities for interventions affecting the clinical progression of the disease.
Similar articles
- REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
Vendette M, Gagnon JF, Décary A, Massicotte-Marquez J, Postuma RB, Doyon J, Panisset M, Montplaisir J. Vendette M, et al. Neurology. 2007 Nov 6;69(19):1843-9. doi: 10.1212/01.wnl.0000278114.14096.74. Neurology. 2007. PMID: 17984452 - Contribution of aging to the severity of different motor signs in Parkinson disease.
Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Levy G, et al. Arch Neurol. 2005 Mar;62(3):467-72. doi: 10.1001/archneur.62.3.467. Arch Neurol. 2005. PMID: 15767513 - Cognitive and behavioural impairment in Parkinson's disease.
Merims D, Freedman M. Merims D, et al. Int Rev Psychiatry. 2008 Aug;20(4):364-73. doi: 10.1080/09540260802095123. Int Rev Psychiatry. 2008. PMID: 18925485 Review. - Mechanisms compensating for dopamine loss in early Parkinson disease.
Brotchie J, Fitzer-Attas C. Brotchie J, et al. Neurology. 2009 Feb 17;72(7 Suppl):S32-8. doi: 10.1212/WNL.0b013e318198e0e9. Neurology. 2009. PMID: 19221312 Review. - Medical management of advanced Parkinson's disease.
Goudreau JL. Goudreau JL. Clin Geriatr Med. 2006 Nov;22(4):753-72, v. doi: 10.1016/j.cger.2006.06.006. Clin Geriatr Med. 2006. PMID: 17000334 Review.
Cited by
- Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease.
Raket LL, Oudin Åström D, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P. Raket LL, et al. Sci Rep. 2022 Jan 11;12(1):526. doi: 10.1038/s41598-021-04356-8. Sci Rep. 2022. PMID: 35017548 Free PMC article. - Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.
Tran J, Anastacio H, Bardy C. Tran J, et al. NPJ Parkinsons Dis. 2020 Apr 24;6:8. doi: 10.1038/s41531-020-0110-8. eCollection 2020. NPJ Parkinsons Dis. 2020. PMID: 32352027 Free PMC article. Review. - Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease.
Tang Y, Li T, Li J, Yang J, Liu H, Zhang XJ, Le W. Tang Y, et al. Cell Death Differ. 2014 Mar;21(3):369-80. doi: 10.1038/cdd.2013.159. Epub 2013 Nov 8. Cell Death Differ. 2014. PMID: 24212761 Free PMC article. - The Body, the Brain, the Environment, and Parkinson's Disease.
Dorsey ER, De Miranda BR, Horsager J, Borghammer P. Dorsey ER, et al. J Parkinsons Dis. 2024;14(3):363-381. doi: 10.3233/JPD-240019. J Parkinsons Dis. 2024. PMID: 38607765 Free PMC article. Review. - Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW, Lee HS, Kang JM, Bae SH, Kim C, Lee SH, Schwarz J, Kim GJ, Kim JS, Cha DH, Kim J, Chang SW, Lee TH, Moon J. Kim HW, et al. Cell Transplant. 2018 May;27(5):814-830. doi: 10.1177/0963689718766324. Epub 2018 Jun 5. Cell Transplant. 2018. PMID: 29871515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical